catalpol has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZL; Cheng, S; Dong, CJ; Gao, WY; Jiang, RH; Yang, JX | 1 |
| Fu, X; Liu, Z; Mao, M; Wu, Y; Yang, A; Zhu, P | 1 |
2 other study(ies) available for catalpol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Catalpol Enhances Random-Pattern Skin Flap Survival by Activating SIRT1-Mediated Enhancement of Autophagy.
Topics: Animals; Autophagy; Iridoid Glucosides; Male; Necrosis; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Sirtuin 1 | 2022 |
Catalpol suppressed proliferation, growth and invasion of CT26 colon cancer by inhibiting inflammation and tumor angiogenesis.
Topics: Animals; Aorta; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Inflammation; Iridoid Glucosides; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Neovascularization, Pathologic; Rats, Sprague-Dawley; Vasoconstriction | 2017 |